Newsletter
Sign up for the Fund's newsletter and get the lastest news, calls and events
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| Flowplan - Intelligent filter management | 2020 - 2020 | Innobooster
|
|
|
Flowplan - Intelligent filter management
Period
2020 - 2020
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
32.26 Invested
400.000 Budget
1.2 mill. Partners
Flowplan ApS People
Flowplan ApS
Read more about the project
| |||
| Flowplan - Intelligent filterhåndtering med IoT | 2019 - 2019 | Innobooster
|
|
|
Flowplan - Intelligent filterhåndtering med IoT
Period
2019 - 2019
Region
Region Hovedstaden Program
Innobooster Area
Produktion, Materialer, Digitalisering og IKT Investment
Percentage
32.65 Invested
320.000 Budget
980.000 Partners
Flowplan IVS People
Flowplan ApS
Read more about the project
| |||
| Flowreaktor til Grafen Produktion | 2023 - 2024 | Innobooster
|
|
|
Flowreaktor til Grafen Produktion
Period
2023 - 2024
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
673.313 Budget
1.9 mill. Partners
Danish Graphene ApS People
Read more about the project
| |||
| Fluidan - Prototype og Validering | 2015 - 2016 | Innobooster
|
|
|
Fluidan - Prototype og Validering
Period
2015 - 2016
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
50 Invested
457.000 Budget
914.000 Partners
FLUIDAN ApS People
FLUIDAN ApS
Read more about the project
| |||
| Fluispotter - Klinisk validering af en ny, innovativ metode til automatiseret 24-timers blodprøvetagning | 2016 - 2020 | Grand Solutions
|
|
|
Fluispotter - Klinisk validering af en ny, innovativ metode til automatiseret 24-timers blodprøvetagning
Period
2016 - 2020
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
74.85 Invested
5.8 mill. Budget
7.7 mill. Partners
Region Hovedstaden, Rigshospitalet, Region Hovedstaden, Rigshospitalet, Hovedstaden, Herlev Hospital, Fluisense ApS People
FLUISENSE ApS
Read more about the project
| |||
| FluoCure FluoCure - taking cancer surgery to cellular precision with targeted photothermal therapy | 2023 - 2027 | Grand Solutions
|
|
|
FluoCure FluoCure - taking cancer surgery to cellular precision with targeted photothermal therapy
Period
2023 - 2027
Region
Program
Grand Solutions Area
Ikke defineret Investment
Percentage
54.83 Invested
27.0 mill. Budget
49.2 mill. Cancer is the second leading cause of death globally with 15 million new cases diagnosed every year. Surgery is a cornerstone in the treatment, and is currently used in 45% of all cancer patients. Despite surgery, cancer recurs in approx. half of the patients. While surgery holds enormous potential, it is greatly underserved.
FluoCure aims to develop and clinically test the FluoCure drug. It is composed of a peptide and a fluorophore bound together by a linker. The peptide binds to urokinase plasminogen activator receptor (uPAR), highly specific for tumors, and the fluorophore enables precise thermal ablation and visualization of cancer cells. FluoCure will disrupt cancer surgery with a cancer-targeted photothermal therapy—bringing cellular precision to surgery.
The ambition is to test the FluoCure drug in a phase I/II trial in high-grade glioma patients. The patients will directly benefit from a lower recurrence rate and higher survival rate. The society will be able to offer advanced treatment and reduce recurrence-related costs. Following successful clinical translation, the FluoCure drug will be used for other indications. The potential is immense, as more than 80% of the solid cancers express uPAR.
This ambitious venture will only be possible with a multidisciplinary team of experts in peptides (UCPH-CHEM), fluorophores (UCPH-FLUO), imaging & cancer models (UCPH-CMI), neurosurgery & clinical trials (RH-Neuro), and business development & regulatory affairs (FluoGuide).
Partners
University of Copenhagen, University of Copenhagen, University of Copenhagen, Copenhagen University Hospital (Rigshospitalet), FluoGuide A/S People
Read more about the project
| |||
| FluoGuide: Optical probe to guide cancer surgeons | 2017 - 2021 | Grand Solutions
|
|
|
FluoGuide: Optical probe to guide cancer surgeons
Period
2017 - 2021
Region
Region Hovedstaden Program
Grand Solutions Area
Biotek, Medico og Sundhed Investment
Percentage
74.27 Invested
10.3 mill. Budget
13.9 mill. Partners
Copenhagen University Hospital (Rigshospitalet), Copenhagen University Hospital (Rigshospitalet), University of Copenhagen, University of Copenhagen, University of Copenhagen, Curasight Aps, Fluoguide IVS, FluoGuide A/S, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52 People
KU - SUND - PANUM KBH N
Read more about the project
| |||
| FluoRAS Fluorescence Water Quality Sensor for Control of Land-Based Aquaculture Systems | 2021 - 2023 | Grand Solutions
|
|
|
FluoRAS Fluorescence Water Quality Sensor for Control of Land-Based Aquaculture Systems
Period
2021 - 2023
Region
Region Hovedstaden Program
Grand Solutions Area
Energi, Klima og Miljø Investment
Percentage
75 Invested
6.4 mill. Budget
8.6 mill. Partners
Technical University of Denmark, Oxyguard A/S People
Danmarks Tekniske Universitet
Read more about the project
| |||
| Fluorescence-free fermentation monitoring with time-gated Raman spectroscopy | 2024 - 2026 | Industrial Researcher
|
|
|
Fluorescence-free fermentation monitoring with time-gated Raman spectroscopy
Period
2024 - 2026
Region
Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
61.52 Invested
828.000 Budget
1.3 mill. Løbende målinger af fermenteringsprocesser med konventionel kontinuert bølgelængde Raman spektroskopi, er meget begrænset grundet en stærk fluorescerende baggrund. Vi foreslår et tidsbegrænset Raman instrument baseret på pulserende excitations lasere, som vil fjerne den fluorescerende baggrund fra Raman målingerne, og demonstrere brugen af denne teknologi til overvågning af fermentering.
Partners
Technical University of Denmark, Lightnovo ApS People
Read more about the project
| |||
| Flydende rottelokkemad, kommunikation og mekanik til mekanisk rottefælde | 2023 - 2024 | Innobooster
|
|
|
Flydende rottelokkemad, kommunikation og mekanik til mekanisk rottefælde
Period
2023 - 2024
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
446.299 Budget
1.3 mill. Partners
Captivis Aps People
Read more about the project
| |||
| FocalX Automated Exterior Car Damage Engine | 2022 - 2022 | Innobooster
|
|
|
FocalX Automated Exterior Car Damage Engine
Period
2022 - 2022
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
488.250 Budget
1.4 mill. Partners
FocalX ApS People
FocalX ApS
Read more about the project
| |||
| FocalX: Remote car damage detection for all | 2023 - 2024 | Innobooster
|
|
|
FocalX: Remote car damage detection for all
Period
2023 - 2024
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
754.688 Budget
2.2 mill. Partners
FocalX ApS People
Read more about the project
| |||
| Foliar biopesticides for protecting wheat against Septoria tritici blotch | 2022 - 2025 | Industrial Researcher
|
|
|
Foliar biopesticides for protecting wheat against Septoria tritici blotch
Period
2022 - 2025
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
100 Invested
1.1 mill. Budget
1.1 mill. Partners
University of Copenhagen, CHR HANSEN A/S People
CHR HANSEN A/S
Read more about the project
| |||
| Folkesundhedsvidenskaber til fitnesscenter | 2022 - 2023 | Innobooster
|
|
|
Folkesundhedsvidenskaber til fitnesscenter
Period
2022 - 2023
Region
Region Nordjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
100 Invested
150.000 Budget
150.000 Partners
MYHEART ApS People
MYHEART ApS
Read more about the project
| |||
| Fondaparinux syntese | 2018 - 2018 | Innobooster
|
|
|
Fondaparinux syntese
Period
2018 - 2018
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
29.75 Invested
495.062 Budget
1.7 mill. Partners
Hepoligo Solutions Aps People
Hepoligo Solutions ApS
Read more about the project
| |||